Table 3.
Medications used by patients with postural tachycardia syndrome (PoTS)
| Primary treatment | Combination | PoTS UK | PoTS clinic |
|---|---|---|---|
| No treatment | 20 (24%) | 17 (32.5%) | |
| β-blocker | Alone | 15 (18%) | 10 (19%) |
| Plus midodrine | 4 (5%) | 2 (4%) | |
| Ivabradine | Alone | 4 (5%) | 7 (13%) |
| Midodrine | 0 | 2 (4%) | |
| Fludrocortisone | 1 (1%) | 1 (2%) | |
| Sertraline | 1 (1%) | 0 | |
| Duloxetine | 1 (1%) | 0 | |
| β-blocker | 0 | 1 (2%) | |
| Diltiazem | Alone | 1 (2%) | |
| Fludrocortisone | 1 (1%) | 0 | |
| Midodrine | 0 | 1 (2%) | |
| Verapamil | Alone | 0 | 1 (2%) |
| Fludrocortisone | Alone | 5 (6%) | 2 (4%) |
| β-blocker | 5 (6%) | 2 (4%) | |
| Midodrine | 5 (6%) | 0 | |
| Midodrine | Alone | 12 (14%) | 4 (7.5%) |
| Buproprion | 1 (1%) | 0 | |
| Octretide | + midodrine + fludro | 2 (2.5%) | 0 |
| Pregabalin | 1 (1%) | 0 | |
| Clonazepam | 1 (1%) | 0 | |
| Antidepressant | 3 (4%) | 0 | |
| Salt only | 2 (2.5%) | 1 (2%) |